Industry Analysis & Industry Trends
The Contract Pharmaceutical Research Services industry experienced hefty growth in the past five years. Moreover, the industry is anticipated to continue its growth streak in the five years to 2020. Rising global competition during this time will limit revenue growth from achieving the double-digit rates that the industry enjoyed in the previous five years. Still, the industry's rise to prominence will transform drug development and production, securing its place in the pharmaceutical value chain.... purchase to read more
Industry Report - Industry Analysis Chapter
Operators in the Contract Pharmaceutical Research Services industry provide a breadth of research and development services to downstream clients in the pharmaceutical industries. In an effort to control costs, achieve greater research productivity and reduce risk, drug manufacturers are increasingly outsourcing their research and development (R&D) functions to industry operators, also referred to as contract research organizations (CRO). In addition, CROs offer drug development expertise and capabilities not found internally, allowing drug developers to scale production more quickly and bring their products to the market.
The advantages offered by CROs have precipitated rapid industry growth in the past five years... purchase to read more